Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
People with pancreatic cancer (12 spots):
- Adults aged 18 or older who have recently been diagnosed with pancreatic cancer (whether it has spread or not) and who have been on tube feeding or IV nutrition for 14 days or less
Within that group, people with cachexia (significant muscle and weight loss — 6 spots):
- People who have lost more than 5% of their body weight without trying over the last 6 months, OR have lost more than 2% of their body weight and have a low body weight (BMI under 20), OR have been found to have significant muscle loss measured by a body composition test
Within that group, people without cachexia (6 spots):
- People whose weight has been stable (within 2%) over the last 6 months, who had a normal appetite before diagnosis, and who have no known issues with blood sugar regulation
Healthy volunteers (12 spots):
- Adults aged 18 or older with a BMI between 18.5 and 30, no ongoing or recent illness, who are matched in gender and age (within 5 years) to a participant with pancreatic cancer already enrolled in the trial
Who may not be able to join:
- People under 18 years of age
- People who are unable to give their own consent to participate
- People who do not have sufficient knowledge of French or German
- People whose pancreatic cancer has already been treated with chemotherapy, radiotherapy, or major surgery such as removal of part of the pancreas or a bile duct bypass procedure
- People with a known rheumatological or immune system disease
- People who have taken antibiotic or immune-suppressing medications (such as steroids, certain cancer drugs, or biological medicines) in the 30 days before joining the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Laurence Genton Graf, Prof, Geneva University Hospitals (HUG)
Phone: +41 22 3729344
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Body weight changes in mice after fecal material transplantation.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.